Tamin Pharmaceutical Investment Company (TPICO), as Iran’s largest pharmaceutical holding company, comprises 24 subsidiaries and operates across a comprehensive range of pharmaceutical industry sectors. In addition to contributing to public health, TPICO is committed to the sustainable development of Iran’s pharmaceutical industry.
Through its subsidiaries—including TAMAD, Iran Antibiotics Production Company, ChlorPars, Iran Capsule Gelatin Company, Tofigh Darou, Darou Pakhsh Pharmaceutical Chemicals, Rahavard Tamin, and Shirin Darou—TPICO plays a fundamental role in supplying the country’s pharmaceutical raw materials by producing high-quality materials for the pharmaceutical industry.
Darou Pakhsh Pharmaceutical Manufacturing Company, Razak Laboratories, Aburaihan Pharmaceutical Company, Pars Darou, Caspian Tamin, Farabi Pharmaceutical Company, Exir Pharmaceutical Company, Zagros Pharmed Pars, Shahid Ghazi Pharmaceutical Company, and Zahravi Pharmaceutical Company manufacture effective, high-quality pharmaceutical products in accordance with international standards, contributing to the improvement of public health.
Darou Pakhsh Distribution Company, Hejrat Distribution Company, Exir Distribution Company, and Darou Pakhsh Veterinary Pharmaceutical Distribution Company play a vital role in ensuring the efficient and timely supply of pharmaceutical products through their extensive and effective distribution networks.
Ozan Trading Company plays a key role in sourcing pharmaceutical raw materials and equipment from international markets by developing and maintaining global business relationships.
By relying on expertise, innovation, and synergy across its companies, TPICO continues its path toward progress, improving public health, and contributing to the development of Iran’s pharmaceutical industry.
